Andrew F. Shorr

23.2k total citations · 5 hit papers
345 papers, 15.9k citations indexed

About

Andrew F. Shorr is a scholar working on Epidemiology, Critical Care and Intensive Care Medicine and Infectious Diseases. According to data from OpenAlex, Andrew F. Shorr has authored 345 papers receiving a total of 15.9k indexed citations (citations by other indexed papers that have themselves been cited), including 179 papers in Epidemiology, 123 papers in Critical Care and Intensive Care Medicine and 83 papers in Infectious Diseases. Recurrent topics in Andrew F. Shorr's work include Nosocomial Infections in ICU (110 papers), Pneumonia and Respiratory Infections (91 papers) and Sepsis Diagnosis and Treatment (52 papers). Andrew F. Shorr is often cited by papers focused on Nosocomial Infections in ICU (110 papers), Pneumonia and Respiratory Infections (91 papers) and Sepsis Diagnosis and Treatment (52 papers). Andrew F. Shorr collaborates with scholars based in United States, Canada and France. Andrew F. Shorr's co-authors include Marya D. Zilberberg, Marin H. Kollef, Scott T. Micek, Steven D. Nathan, Ying P. Tabak, Christopher J. Lettieri, Vikas Gupta, William L. Jackson, Larry Z. Liu and Donald L. Helman and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Andrew F. Shorr

334 papers receiving 15.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidemiology and Outcomes of Health-care–Associated Pneumonia

2005 721 citations Marin H. Kollef, Andrew F. Shorr et al. CHEST Journal profile →
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis

2006 600 citations Steven D. Nathan, Scott D. Barnett et al. CHEST Journal profile →
Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study

2012 402 citations Richard G. Wunderink, Marin H. Kollef et al. Clinical Infectious Diseases profile →
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial

2020 319 citations Richard G. Wunderink, Marin H. Kollef et al. profile →
Efficacy and safety of sulbactam–durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii–calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)

2023 146 citations Andrew F. Shorr, Richard G. Wunderink et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew F. Shorr United States	73	6.3k	4.2k	4.0k	3.9k	2.4k	345	15.9k
Jean‐François Timsit France	68	5.6k 0.9×	2.8k 0.7×	3.9k 1.0×	2.7k 0.7×	2.1k 0.9×	345	14.3k
Naomi P. O’Grady United States	36	5.0k 0.8×	2.9k 0.7×	3.8k 0.9×	2.9k 0.7×	1.1k 0.5×	57	15.5k
Stijn Blot Belgium	63	5.8k 0.9×	2.4k 0.6×	3.5k 0.9×	3.5k 0.9×	1.3k 0.5×	266	12.4k
Kevin B. Laupland Canada	72	5.6k 0.9×	2.7k 0.6×	3.0k 0.7×	3.2k 0.8×	4.4k 1.9×	364	17.1k
Jordi Carratalà Spain	63	8.6k 1.4×	1.7k 0.4×	2.9k 0.7×	2.8k 0.7×	2.3k 1.0×	332	14.2k
Ignacio Martín‐Loeches Ireland	56	7.0k 1.1×	2.4k 0.6×	4.1k 1.0×	2.3k 0.6×	1.4k 0.6×	369	12.9k
Richard G. Wunderink United States	73	12.9k 2.0×	4.9k 1.2×	6.9k 1.7×	4.2k 1.1×	4.2k 1.8×	321	23.7k
Christian Brun‐Buisson France	72	7.3k 1.2×	6.4k 1.5×	6.7k 1.7×	2.0k 0.5×	1.5k 0.6×	281	18.9k
Thomas M. File United States	51	15.1k 2.4×	2.8k 0.7×	4.4k 1.1×	3.9k 1.0×	3.1k 1.3×	266	21.4k
Michael S. Niederman United States	65	14.6k 2.3×	5.0k 1.2×	7.6k 1.9×	2.5k 0.6×	2.8k 1.2×	256	21.1k

Countries citing papers authored by Andrew F. Shorr

Since Specialization

Citations

This map shows the geographic impact of Andrew F. Shorr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew F. Shorr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew F. Shorr more than expected).

Fields of papers citing papers by Andrew F. Shorr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew F. Shorr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew F. Shorr. The network helps show where Andrew F. Shorr may publish in the future.

Co-authorship network of co-authors of Andrew F. Shorr

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew F. Shorr. A scholar is included among the top collaborators of Andrew F. Shorr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew F. Shorr. Andrew F. Shorr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zilberberg, Marya D., et al.. (2025). Comparative Outcomes of Meropenem–Vaborbactam vs. Ceftazidime–Avibactam Among Adults Hospitalized with an Infectious Syndrome in the US, 2019–2021. Antibiotics. 14(1). 29–29. 5 indexed citations

Shorr, Andrew F., et al.. (2024). At the Intersection of Critical Care and Infectious Diseases: The Year in Review. Biomedicines. 12(3). 562–562. 2 indexed citations

Shorr, Andrew F., et al.. (2023). Bloodstream Infection and Gram-Negative Resistance: The Role for Newer Antibiotics. Antibiotics. 12(6). 977–977. 1 indexed citations

Martín‐Loeches, Ignacio, Andrew F. Shorr, Marin H. Kollef, et al.. (2023). Participant- and Disease-Related Factors as Independent Predictors of Treatment Outcomes in the RESTORE-IMI 2 Clinical Trial: A Multivariable Regression Analysis. Open Forum Infectious Diseases. 10(6). ofad225–ofad225. 2 indexed citations

Bassetti, Matteo, José Garnacho‐Montero, Thierry Calandra, et al.. (2017). Intensive care medicine research agenda on invasive fungal infection in critically ill patients. Intensive Care Medicine. 43(9). 1225–1238. 126 indexed citations

McEvoy, Colleen, et al.. (2014). Macrolides Are Associated with a Better Survival Rate in Patients Hospitalized with Community-Acquired But Not Healthcare-Associated Pneumonia. Surgical Infections. 15(3). 283–289. 6 indexed citations

Zilberberg, Marya D., Andrew F. Shorr, Scott T. Micek, & Marin H. Kollef. (2014). Clostridium difficile Recurrence Is a Strong Predictor of 30-Day Rehospitalization Among Patients in Intensive Care. Infection Control and Hospital Epidemiology. 36(3). 273–279. 11 indexed citations

Kleinschmidt, Kurt, Phillip D. Levy, Allison Wyman, et al.. (2014). Emergency Department Patients With Acute Severe Hypertension. Critical Pathways in Cardiology A Journal of Evidence-Based Medicine. 13(2). 66–72. 2 indexed citations

Zilberberg, Marya D., Scott T. Micek, Marin H. Kollef, Ahmed Shelbaya, & Andrew F. Shorr. (2012). Risk Factors for Mixed Complicated Skin and Skin Structure Infections To Help Tailor Appropriate Empiric Therapy. Surgical Infections. 13(6). 377–382. 12 indexed citations

10.

Goyal, Munish, Anish K. Agarwal, Byron C. Drumheller, et al.. (2012). 698. Critical Care Medicine. 40. 1–328. 1 indexed citations

11.

Micek, Scott T., Victor Pham, Joshua A. Doherty, et al.. (2010). Bacteremia Increases the Risk of Death among Patients with Soft-Tissue Infections. Surgical Infections. 11(2). 169–176. 11 indexed citations

12.

Zilberberg, Marya D., Samir H. Mody, Joyce Chen, & Andrew F. Shorr. (2010). Cost-Effectiveness Model of Empiric Doripenem Compared with Imipenem-Cilastatin in Ventilator-Associated Pneumonia. Surgical Infections. 11(5). 409–417. 9 indexed citations

13.

Shorr, Andrew F., Jonathan Janes, Antonio Artigas, et al.. (2010). Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated). Critical Care. 14(6). R229–R229. 14 indexed citations

14.

Zilberberg, Marya D. & Andrew F. Shorr. (2010). Ventilator‐Associated Pneumonia: The Clinical Pulmonary Infection Score as a Surrogate for Diagnostics and Outcome. Clinical Infectious Diseases. 51(S1). S131–S135. 133 indexed citations

15.

Tabak, Ying P., Xiaowu Sun, Richard S. Johannes, Vikas Gupta, & Andrew F. Shorr. (2009). Mortality and Need for Mechanical Ventilation in Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Archives of Internal Medicine. 169(17). 1595–602. 88 indexed citations

16.

Perkins, Jeremy G., Philip C. Spinella, Lorne H. Blackbourne, et al.. (2009). An Evaluation of the Impact of Apheresis Platelets Used in the Setting of Massively Transfused Trauma Patients. The Journal of Trauma: Injury, Infection, and Critical Care. 66(4). S77–S85. 122 indexed citations

17.

Shorr, Andrew F., et al.. (2004). Potential Limitations of Clinical Criteria for the Diagnosis of Idiopathic Pulmonary Fibrosis/Cryptogenic Fibrosing Alveolitis. Respiration. 71(2). 165–169. 19 indexed citations

18.

Nathan, Steven D., Scott D. Barnett, Donald L. Helman, et al.. (2004). Interferon gamma-1b as Therapy for Idiopathic Pulmonary Fibrosis. Respiration. 71(1). 77–82. 13 indexed citations

19.

Shorr, Andrew F. & Richard G. Wunderink. (2003). Dollars and sense in the intensive care unit: The costs of ventilator-associated pneumonia *. Critical Care Medicine. 31(5). 1582–1583. 12 indexed citations

20.

Shorr, Andrew F., et al.. (2002). D-dimer Correlates With Proinflammatory Cytokine Levels and Outcomes in Critically Ill Patients. CHEST Journal. 121(4). 1262–1268. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact